Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathwaySushil Kumar(Indian Institute of Science Education and Research, Bhopal), Rumela Chakrabarti(University of Pennsylvania)Nature CommunicationsJanuary 18, 202110.1038/s41467-020-20664-5Cited by 80SaveCiteExport RISWatch citationsRelated PapersIPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity|Cell Death and Disease|2015|48ΔNp63 regulates MDSC survival and metabolism in triple-negative breast cancer|iScience|2024|8